SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-031308
Filing Date
2018-05-08
Accepted
2018-05-08 16:16:26
Documents
15
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-13044_18k.htm 8-K 28272
2 EX-99.1 a18-13044_1ex99d1.htm EX-99.1 115956
3 EX-99.2 a18-13044_1ex99d2.htm EX-99.2 20339
4 GRAPHIC g130441mm01i001.jpg GRAPHIC 3905
5 GRAPHIC g130441moi001.gif GRAPHIC 34431
6 GRAPHIC g130441moi002.gif GRAPHIC 148348
7 GRAPHIC g130441moi003.gif GRAPHIC 108065
8 GRAPHIC g130441moi004.gif GRAPHIC 79537
9 GRAPHIC g130441moi005.gif GRAPHIC 60891
10 GRAPHIC g130441moi006.gif GRAPHIC 71221
11 GRAPHIC g130441moi007.gif GRAPHIC 82041
12 GRAPHIC g130441moi008.gif GRAPHIC 64388
13 GRAPHIC g130441moi009.gif GRAPHIC 42802
14 GRAPHIC g130441moi010.gif GRAPHIC 100043
15 GRAPHIC g130441moi011.gif GRAPHIC 88541
  Complete submission text file 0001104659-18-031308.txt   1384791
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 18814767
SIC: 2834 Pharmaceutical Preparations